By Jonathan Stempel July 1 (Reuters) - A federal judge on Wednesday blocked Colorado from capping the price of Amgen's ...

June 29 (Reuters) - The New England Journal of Medicine on Monday retracted an article on a pivotal clinical trial that ...

Roche (RHHBY) unit Genentech announced on Thursday its KRAS G12C inhibitor divarasib outperformed FDA-approved KRAS G12C inhibitors from Amgen (AMGN) and Bristol Myers Squibb (BMY) in a late-stage ...

A clinical trial used to approve Amgen Inc.’s pill Tavneos was retracted Monday from the New England Journal of Medicine, ...

As Amgen’s rare disease medicine Tavneos comes under intensifying pressure from the FDA, the company faces a new hurdle with ...

If you are wondering whether Amgen stock still offers value at current levels, this article walks through what the numbers ...

Viridian Therapeutics has scored an FDA approval for Lumvoa to treat thyroid eye disease (TED), triggering competition with ...

Weigh the financial strength of a pharma leader against the rapid growth, and risks, of a biotech newcomer as both navigate ...

The tablets involved in the recall were distributed in the U.S. from Oct. 28, 2021, to Dec. 30, 2025 ...

Alliance police say the suspect's mom helped him "stage the scene as a suicide by placing the firearm next to the deceased ...

Here’s how to tell if your prescriptions are affected—and what to do about it.